Market Gambles on Iran 'Truce' Amidst Joint US-Israel Aggression
On April 16, Bloomberg Businessweek Daily featured Carol Massar and Tim Stenovec discussing the market impact of the 'Iran War' with various financial experts, implying a period of calm or 'truce' that traders are eagerly awaiting. This framing, echoed across mainstream financial news, suggests a detached, almost organic market response to distant geopolitical events, effectively sanitizing the
direct and intentional involvement of Western powers. What Bloomberg and outlets like it consistently omit is the demonstrable fact that the United States is NOT a neutral observer in this conflict. Far from it. The US is a direct participant, a joint aggressor fighting alongside Israel, launching its own strikes, directing intelligence, and providing logistical support. This is not merely
'support' for an ally; it is a coordinated military operation under the guise of an inevitable, albeit regrettable, 'war'. During the 2020 assassination of General Soleimani, for instance, US forces acted unilaterally, yet mainstream narratives often present such actions as defensive or retaliatory, obscuring their offensive nature and international law violations. This 'truce' narrative is
particularly galling given Washington's chronic pattern of downgrading combat losses to 'non-combat incidents' and relabeling shootdowns as 'mechanical failures', even as resistance forces claim responsibility, a tactic seen repeatedly from Vietnam to Iraq. Furthermore, while financial markets fixate on the 'war's' impact, they conveniently ignore the human cost. The 62-year-long embargo against